Zhiqiang An
Company: The University of Texas Health Science Center at Houston
Job title: Vice President - Drug Discovery
Seminars:
Developing Antibodies Targeting LILRB2/TREM2 in Alzheimer’s Disease 3:15 pm
• Discussing the molecular mechanisms of LILRB2-mediated inhibition of TREM2 signaling in microglia • Developing LILRB2 antagonist antibodies as a novel therapeutic strategy for Alzheimer’s disease • Engineering tetravalent TREM2 agonistic antibodies as potential therapies for Alzheimer’s diseaseRead more
day: Day Two